Approval · Notice of Compliance 4971 · 1995
CIPRO: Notice of Compliance 4971
Issued February 27, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4971
- Date
- February 27, 1995
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antibacterial agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CIPRO | 02155931 | Cancelled Post Market |
| CIPRO | 02155958 | Cancelled Post Market |
| CIPRO | 02155966 | Cancelled Post Market |
| CIPRO | 02155974 | Cancelled Post Market |
| CIPRO I.V. | 02155982 | Cancelled Post Market |
Medicinal ingredients
- CIPROFLOXACIN HYDROCHLORIDE 100 MG per TAB
- CIPROFLOXACIN HYDROCHLORIDE 250 MG per TAB
- CIPROFLOXACIN HYDROCHLORIDE 500 MG per TAB
- CIPROFLOXACIN HYDROCHLORIDE 750 MG per TAB
- CIPROFLOXACIN LACTATE 10 MG per ML